These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7918679)

  • 41. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
    Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
    JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
    Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
    Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care.
    Schneider-Yin X; Gouya L; Meier-Weinand A; Deybach JC; Minder EI
    Eur J Pediatr; 2000 Oct; 159(10):719-25. PubMed ID: 11039124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel stop codon mutation (X417L) of the ferrochelatase gene in bovine protoporphyria, a natural animal model of the human disease.
    Jenkins MM; LeBoeuf RD; Ruth GR; Bloomer JR
    Biochim Biophys Acta; 1998 Oct; 1408(1):18-24. PubMed ID: 9784594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion.
    Magness ST; Brenner DA
    Biochim Biophys Acta; 1999 Jan; 1453(1):161-74. PubMed ID: 9989256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
    Risheg H; Chen FP; Bloomer JR
    Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
    Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
    Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.
    Wang Y; Langer NB; Shaw GC; Yang G; Li L; Kaplan J; Paw BH; Bloomer JR
    Exp Hematol; 2011 Jul; 39(7):784-94. PubMed ID: 21627978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.
    Najahi-Missaoui W; Dailey HA
    Blood; 2005 Aug; 106(3):1098-104. PubMed ID: 15831704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.
    Rüfenacht UB; Gouya L; Schneider-Yin X; Puy H; Schäfer BW; Aquaron R; Nordmann Y; Minder EI; Deybach JC
    Am J Hum Genet; 1998 Jun; 62(6):1341-52. PubMed ID: 9585598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families.
    Schneider-Yin X; Rüfenacht UB; Hergersberg M; Schnyder C; Deybach JC; Minder EI
    J Invest Dermatol; 2001 Dec; 117(6):1521-5. PubMed ID: 11886517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythropoietic protoporphyria: four novel frameshift mutations in the ferrochelatase gene.
    Wang X; Piomelli S; Peacocke M; Christiano AM; Poh-Fitzpatrick MB
    J Invest Dermatol; 1997 Nov; 109(5):688-91. PubMed ID: 9347801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.
    Ohgari Y; Sawamoto M; Yamamoto M; Kohno H; Taketani S
    Hum Mol Genet; 2005 Jan; 14(2):327-34. PubMed ID: 15574461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoietic protoporphyria: a new mutation responsible for exon skipping in the human ferrochelatase gene.
    Remenyik E; Lanyon GW; Horkay I; Paragh G; Wikonkál N; Kósa A; Moore MR
    J Invest Dermatol; 1998 Sep; 111(3):540-1. PubMed ID: 9740256
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.
    Long ZB; Wang YW; Yang C; Liu G; Du YL; Nie GJ; Chang YZ; Han B
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):813-820. PubMed ID: 27704751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel mutation of the ferrochelatase gene in a Japanese family with erythropoietic protoporphyria.
    Saito A; Okiyama N; Inoue S; Kubota N; Nakamura Y; Ishitsuka Y; Watanabe R; Nakano H; Fujisawa Y
    J Dermatol; 2020 Apr; 47(4):e114-e116. PubMed ID: 32056258
    [No Abstract]   [Full Text] [Related]  

  • 57. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of erythropoietic protoporphyria in South Africa.
    Parker M; Corrigall AV; Hift RJ; Meissner PN
    Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria.
    Di Pierro E; Brancaleoni V; Moriondo V; Besana V; Cappellini MD
    Clin Genet; 2007 Jan; 71(1):84-8. PubMed ID: 17204051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
    Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
    Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.